Emerging Roles and Therapeutic Applications of Arachidonic Acid Pathways in Cardiometabolic Diseases

Yufeng Hu1,2, Wei Li3, Xu Cheng1,2

  • 1State Key Laboratory of New Targets Discovery and Drug Development for Major Diseases, Gannan Innovation and Translational Medicine Research Institute, Gannan Medical University, Ganzhou, China (Y.H., X.C., H.Y., Z.-G.S., J.C., H.L., X.-J.Z.).

Circulation Research
|June 20, 2024
PubMed

Insights

Arachidonic acid pathways are key in cardiometabolic diseases like heart failure and diabetes. Targeting these pathways offers new therapeutic strategies for these widespread conditions.

Area of Science:

  • Biochemistry
  • Cardiovascular Medicine
  • Metabolic Disorders

Background:

  • Cardiometabolic disease presents a significant global health challenge with limited treatment options.
  • Arachidonic acid pathways are increasingly recognized for their role in linking metabolic dysfunction to cardiovascular disease.
  • These pathways are implicated in the progression and severity of various cardiometabolic conditions.

Purpose of the Study:

  • To systematically review the biological functions of arachidonic acid pathways in major cardiometabolic diseases.
  • To elucidate the cellular and molecular mechanisms underlying arachidonic acid pathway regulation in these diseases.
  • To highlight emerging clinical strategies targeting arachidonic acid metabolites for improved patient outcomes.

Main Methods:

  • Systematic literature review and synthesis of existing research.
  • Analysis of cellular and molecular mechanisms.
  • Review of current clinical advances and therapeutic targets.

Main Results:

  • Arachidonic acid derivatives and pathway factors are integral to heart failure, hypertension, atherosclerosis, nonalcoholic fatty liver disease, obesity, and diabetes.
  • Detailed understanding of the molecular and cellular roles of these pathways in disease pathogenesis.
  • Identification of potential therapeutic targets within the arachidonic acid pathway.

Conclusions:

  • Arachidonic acid pathways are crucial mediators in cardiometabolic disease development and progression.
  • Targeting specific arachidonic acid metabolites and pathway factors shows promise for novel therapeutic interventions.
  • Further research into these pathways can lead to improved management of cardiometabolic disorders.

Related Concept Videos

Lipid-derived Compounds in the Human Body01:31

Lipid-derived Compounds in the Human Body

Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various  biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
4.3K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Overview of Fatty Acid Metabolism01:28

Overview of Fatty Acid Metabolism

Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
30.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.8K